In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Enterome Bioscience SA

Latest From Enterome Bioscience SA

Pacts In Medtech, July/August 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.

Deals Pacts in Medtech

Appointments: G1 Therapeutics, Breath Therapeutics, Fortress Biotech, Freeline Therapeutics, Enterome and Symic Bio

GSK's former CEO Sir Andrew Witty has joined the board of directors of the oncology company, G1 Therapeutics. This week's roundup also includes CEO appointments by Fortress Biotech, Freeline Therapeutics and BridgeSat, in addition to various other high-level appointments by Nabriva Therapeutics, Caribou Biosciences, Symic Bio and Breath Therapeutics.

BioPharmaceutical Appointments

Enterome Building A Microbiome R&D Presence Via Pharma Deals

The number of microbiome-based companies is growing with scientific breakthroughs in this area. Pierre Belichard, CEO of the French gut microbiome focused company Enterome, talked to Scrip at the Biotrinity 2017 meeting in London about its partnerships, pipeline progress and his plans for the future.

Companies Research & Development

In Vivo's Deals Of The Month, April 2017

In Vivo's editors pick April's most significant deals, including BD's acquisition of Bard and Takeda's microbiome deals. (Free article.)

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Hepatic (Liver)
  • Metabolic Disorders
  • Alias(es)
  • Enterome
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Enterome Bioscience SA
  • Senior Management
  • Pierre Belichard, PhD, CEO
    Christophe Bonny, PhD, CSO
    Rodolphe Clerval, CBO
    Christelle Dumoussaud, Head of Fin. & Admin.
  • Contact Info
  • Enterome Bioscience SA
    Phone: 1 75 77 27 85
    94/96 avenue Ledru-Rollin
    Paris, 75011